DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma

DEAD-box protein 39 (DDX39) has been demonstrated to be a tumorigenic gene in multiple tumor types, but its role in the progression and immune microenvironment of clear cell renal cell cancer (ccRCC) remains unclear. The aim of the present study was to investigate the role of DDX39 in the ccRCC tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Yewei, Jiang, Aimin, Dong, Kai, Gan, Xinxin, Gong, Wenliang, Wu, Zhenjie, Liu, Bing, Bao, Yi, Wang, Jie, Wang, Linhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375229/
https://www.ncbi.nlm.nih.gov/pubmed/34421357
http://dx.doi.org/10.7150/ijbs.62553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375229/
https://www.ncbi.nlm.nih.gov/pubmed/34421357
http://dx.doi.org/10.7150/ijbs.62553

Ejemplares similares